Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Agios Pharmaceuticals Inc (AGIO)  
$30.21 0.68 (2.3%) as of 4:30 Mon 4/22


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 69,110,000
Market Cap: 2.09(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $19.97 - $34.81
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Agios Pharmaceuticals is a biopharmaceutical company focused on improving patients' lives in the field of cellular metabolism and adjacent areas of biology, with the goal of creating molecule medicines for genetically defined diseases (GDD). The lead product in its GDD, portfolio, PYRUKYND® (mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the potential treatment of hemolytic anemias. Co. is evaluating PYRUKYND® for the treatment of a- and B-thalassemia and sickle cell disease (SCD). Co. is also developing AG-946, a PK activator, for the potential treatment of hemolytic anemias and other indications, including SCD.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 191,742 218,053 292,572 410,176
Total Sell Value $6,091,462 $6,694,407 $8,693,794 $11,787,151
Total People Sold 9 9 9 9
Total Sell Transactions 23 28 39 48
End Date 2024-01-21 2023-10-20 2023-04-21 2022-04-21

   
Records found: 822
  Page 1 of 33  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Fouse Jacqualyn A Director   –       •      –    2024-04-10 4 AS $27.55 $214,642 D/D (7,791) 137,396 -1%     
   Fouse Jacqualyn A Director   –       •      –    2024-04-08 4 OE $0.00 $0 D/D 15,934 145,187     -
   Foster-Cheek Kaye I Director   –       •      –    2024-03-07 4 S $31.62 $40,632 D/D (1,285) 5,524 6%     
   Foster-Cheek Kaye I Director   –       •      –    2024-03-06 4 S $31.99 $141,236 D/D (4,415) 6,809 7%     
   Foster-Cheek Kaye I Director   –       •      –    2024-03-05 4 S $32.21 $9,663 D/D (300) 11,224 6%     
   Washburn Theodore James Jr. Principal Accounting Officer   •       –      –    2024-03-05 4 S $31.75 $60,738 D/D (1,913) 2,886 6%     
   Washburn Theodore James Jr. Principal Accounting Officer   •       –      –    2024-03-05 4 AS $32.57 $39,540 D/D (1,214) 4,799 -6%     
   Goff Brian Chief Executive Officer   •       •      –    2024-03-05 4 AS $32.57 $135,361 D/D (4,156) 53,780 -6%     
   Jones Cecilia Chief Financial Officer   •       –      –    2024-03-05 4 AS $32.57 $21,887 D/D (672) 14,840 -6%     
   Gheuens Sarah Chief Medical Officer   •       –      –    2024-03-05 4 AS $32.57 $86,050 D/D (2,642) 39,066 -6%     
   Burns James William Chief Legal Officer   •       –      –    2024-03-05 4 AS $32.57 $86,050 D/D (2,642) 37,169 -6%     
   Washburn Theodore James Jr. Principal Accounting Officer   •       –      –    2024-03-01 4 OE $0.00 $0 D/D 3,127 5,718     -
   Goff Brian Chief Executive Officer   •       •      –    2024-03-01 4 OE $0.00 $0 D/D 8,500 57,936     -
   Jones Cecilia Chief Financial Officer   •       –      –    2024-03-01 4 OE $0.00 $0 D/D 2,000 15,512     -
   Gheuens Sarah Chief Medical Officer   •       –      –    2024-03-01 4 OE $0.00 $0 D/D 7,834 40,415     -
   Burns James William Chief Legal Officer   •       –      –    2024-03-01 4 OE $0.00 $0 D/D 7,834 38,518     -
   Schenkein David P Director   –       •      –    2024-02-27 4 S $33.60 $2,403,592 D/D (69,329) 122,854 15%     
   Schenkein David P Director   –       •      –    2024-02-27 4 OE $31.64 $2,193,570 D/D 69,329 180,325     -
   Schenkein David P Director   –       •      –    2024-02-26 4 S $33.19 $677,441 D/D (20,411) 122,854 10%     
   Schenkein David P Director   –       •      –    2024-02-26 4 OE $31.64 $645,804 D/D 20,411 143,265     -
   Schenkein David P Director   –       •      –    2024-02-23 4 S $33.05 $1,577,510 D/D (47,731) 122,854 10%     
   Schenkein David P Director   –       •      –    2024-02-23 4 OE $31.64 $1,510,209 D/D 47,731 170,585     -
   Washburn Theodore James Jr. Principal Accounting Officer   •       –      –    2024-02-20 4 S $26.63 $13,422 D/D (504) 2,741 -9%     
   Gheuens Sarah Chief Medical Officer   •       –      –    2024-02-14 4 AS $25.14 $16,140 D/D (642) 33,431 14%     
   Washburn Theodore James Jr. Principal Accounting Officer   •       –      –    2024-02-14 4 AS $25.14 $6,863 D/D (273) 3,245 14%     
  822 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 33
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us